|
LM_ID
|
Common Name
|
Systematic Name
|
Species Shorthand
|
Formula
|
Mass
|
|
LMFA01030558
|
Isanic acid
|
17-octadecene-9,11-diynoic acid
|
FA 18:5
|
C18H26O2
|
274.193280
|
|
LMFA01030557
|
Bolekic acid
|
13Z-octadecene-9,11-diynoic acid
|
FA 18:5
|
C18H26O2
|
274.193280
|
|
LMFA01150073
|
(+)-petromyric acid A
|
(2S,3S,5R)-tetrahydro-3-hydroxy-5-[(1R)-1-hydroxyhexyl]-2-furanoctanoic acid
|
FA 18:1;O3
|
C18H34O5
|
330.240626
|
|
LMFA01031055
|
3Z,9Z,12Z-Octadecatrienoic acid
|
3Z,9Z,12Z-Octadecatrienoic acid
|
FA 18:3
|
C18H30O2
|
278.224581
|
|
LMFA01031051
|
8E,10E-Octadecadien-12-ynoic acid
|
8E,10E-Octadecadien-12-ynoic acid
|
FA 18:4
|
C18H28O2
|
276.208930
|
|
LMFA01050602
|
2R-hydroxy-goshuyic acid
|
2R-hydroxy-5Z,8Z-tetradecadienoic acid
|
FA 14:2;O
|
C14H24O3
|
240.172545
|
|
LMFA07100007
|
methyl-2R-hydroxy-goshuyic acid
|
methyl 2R-hydroxy-5Z,8Z-tetradecadienoate
|
SFE 15:2;O
|
C15H26O3
|
254.188195
|
|
LMFA07100007
|
methyl-2R-hydroxy-goshuyic acid
|
methyl 2R-hydroxy-5Z,8Z-tetradecadienoate
|
SFE 15:2;O
|
C15H26O3
|
254.188195
|
|
LMFA01030296
|
5Z-octadecenoic acid
|
5Z-octadecenoic acid
|
FA 18:1
|
C18H34O2
|
282.255881
|
|
LMFA01030065
|
Thalictric acid
|
5E-octadecenoic acid
|
FA 18:1
|
C18H34O2
|
282.255881
|
|
LMFA01030815
|
Columbinic acid
|
5E,9Z,12Z-octadecatrienoic acid
|
FA 18:3
|
C18H30O2
|
278.224581
|
|
LMFA01140109
|
Tripmycin A
|
13-(2-methylphenyl)-12E-tridecenoic acid
|
FA 20:5
|
C20H30O2
|
302.224581
|
|
LMFA01140110
|
|
5-(2-Methylphenyl)-4-pentenoic acid
|
FA 12:5
|
C12H14O2
|
190.099380
|
|
LMFA03010151
|
PGE2-EA
|
N-(11R,15S-dihydroxy-9-oxo-5Z,13E-prostadienoyl)-ethanolamine
|
NAE 20:4;O3
|
C22H37NO5
|
395.267174
|
|
LMFA03010151
|
PGE2-EA
|
N-(11R,15S-dihydroxy-9-oxo-5Z,13E-prostadienoyl)-ethanolamine
|
NAE 20:4;O3
|
C22H37NO5
|
395.267174
|
|
LMFA03010151
|
PGE2-EA
|
N-(11R,15S-dihydroxy-9-oxo-5Z,13E-prostadienoyl)-ethanolamine
|
NAE 20:4;O3
|
C22H37NO5
|
395.267174
|
|
LMFA03010151
|
PGE2-EA
|
N-(11R,15S-dihydroxy-9-oxo-5Z,13E-prostadienoyl)-ethanolamine
|
NAE 20:4;O3
|
C22H37NO5
|
395.267174
|
|
LMFA03010075
|
PGF2alpha-EA
|
N-(9S,11R,15S-trihydroxy-5Z,13E-prostadienoyl)-ethanolamine
|
NAE 20:3;O3
|
C22H39NO5
|
397.282824
|
|
LMFA03010075
|
PGF2alpha-EA
|
N-(9S,11R,15S-trihydroxy-5Z,13E-prostadienoyl)-ethanolamine
|
NAE 20:3;O3
|
C22H39NO5
|
397.282824
|
|
LMFA03010075
|
PGF2alpha-EA
|
N-(9S,11R,15S-trihydroxy-5Z,13E-prostadienoyl)-ethanolamine
|
NAE 20:3;O3
|
C22H39NO5
|
397.282824
|
|
LMFA03010152
|
PGD2-EA
|
N-(9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoyl)-ethanolamine
|
NAE 20:4;O3
|
C22H37NO5
|
395.267174
|
|
LMFA03010152
|
PGD2-EA
|
N-(9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoyl)-ethanolamine
|
NAE 20:4;O3
|
C22H37NO5
|
395.267174
|
|
LMFA03010152
|
PGD2-EA
|
N-(9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoyl)-ethanolamine
|
NAE 20:4;O3
|
C22H37NO5
|
395.267174
|
|
LMFA03010152
|
PGD2-EA
|
N-(9S,15S-dihydroxy-11-oxo-5Z,13E-prostadienoyl)-ethanolamine
|
NAE 20:4;O3
|
C22H37NO5
|
395.267174
|
|
LMFA07090168
|
Glc-10/10/10/10-gly
|
N-((((3R-O-beta-d-glucopyranosyl-decanoyloxy)-3R-decanoyloxy)-3R-decanoyloxy)-decanoyl)-glycine
|
|
C48H87NO15
|
917.607575
|
|
LMFA07090169
|
Glc-6/10/10/10-gly
|
N-((((3R-O-beta-d-glucopyranosyl-hexanoyloxy)-3R-decanoyloxy)-3R-decanoyloxy)-decanoyl)-glycine
|
|
C44H79NO15
|
861.544975
|
|
LMFA07090170
|
Glc-10/8/10/10-gly
|
N-((((3R-O-beta-d-glucopyranosyl-decanoyloxy)-3R-octanoyloxy)-3R-decanoyloxy)-decanoyl)-glycine
|
|
C46H83NO15
|
889.576275
|
|
LMFA07090171
|
Glc-10/10/8/10-gly
|
N-((((3R-O-beta-d-glucopyranosyl-decanoyloxy)-3R-decanoyloxy)-3R-octanoyloxy)-decanoyl)-glycine
|
|
C46H83NO15
|
889.576275
|
|
LMFA07090172
|
Glc-8/10/10/10-gly
|
N-((((3R-O-beta-d-glucopyranosyl-octanoyloxy)-3R-decanoyloxy)-3R-decanoyloxy)-decanoyl)-glycine
|
|
C46H83NO15
|
889.576275
|
|
LMFA07090173
|
Glc-10/10/10/8-gly
|
N-((((3R-O-beta-d-glucopyranosyl-decanoyloxy)-3R-decanoyloxy)-3R-decanoyloxy)-octanoyl)-glycine
|
|
C46H83NO15
|
889.576275
|
|
LMFA07090174
|
Glc-10/10/10/12-gly
|
N-((((3R-O-beta-d-glucopyranosyl-decanoyloxy)-3R-decanoyloxy)-3R-decanoyloxy)-dodecanoyl)-glycine
|
|
C50H91NO15
|
945.638875
|
|
LMFA07090175
|
Glc-12/10/10/10-gly
|
N-((((3R-O-beta-d-glucopyranosyl-dodecanoyloxy)-3R-decanoyloxy)-3R-decanoyloxy)-decanoyl)-glycine
|
|
C50H91NO15
|
945.638875
|
|
LMFA01050603
|
20-HEPE
|
20-hydroxy-(5Z,8Z,11Z,14Z,17Z)-eicosapentaenoic acid
|
FA 20:5;O
|
C20H30O3
|
318.219496
|
|
LMFA01050604
|
22-HDHA
|
22-hydroxy-4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoic acid
|
FA 22:6;O
|
C22H32O3
|
344.235146
|
|
LMFA01030764
|
cis-parinaric acid
|
9Z,11E,13E,15Z-octadecatetraenoic acid
|
FA 18:4
|
C18H28O2
|
276.208930
|
|
LMFA07070120
|
3S,7Z-hydroxytetradecenoylcarnitine
|
3-{[(7Z)-3-hydroxytetradec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 14:1;O
|
C21H39NO5
|
385.282824
|
|
LMFA07070120
|
3S,7Z-hydroxytetradecenoylcarnitine
|
3-{[(7Z)-3-hydroxytetradec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 14:1;O
|
C21H39NO5
|
385.282824
|
|
LMFA07070121
|
3S,5Z-hydroxydodecenoylcarnitine
|
3S-{[(5Z)-3-hydroxydodec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 12:1;O
|
C19H35NO5
|
357.251524
|
|
LMFA07070121
|
3S,5Z-hydroxydodecenoylcarnitine
|
3S-{[(5Z)-3-hydroxydodec-7-enoyl]oxy}-4-(trimethylazaniumyl)butanoate
|
CAR 12:1;O
|
C19H35NO5
|
357.251524
|
|
LMFA07070122
|
2E,9Z-Hexadecadienoylcarnitine
|
3-[(2E,9Z)-hexadeca-2,9-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:2
|
C23H41NO4
|
395.303559
|
|
LMFA07070122
|
2E,9Z-Hexadecadienoylcarnitine
|
3-[(2E,9Z)-hexadeca-2,9-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:2
|
C23H41NO4
|
395.303559
|
|
LMFA07070123
|
2E,7Z-tetradecadienoylcarnitine
|
3-[(2E,7Z)-tetradeca-2,7-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 14:2
|
C21H37NO4
|
367.272259
|
|
LMFA07070123
|
2E,7Z-tetradecadienoylcarnitine
|
3-[(2E,7Z)-tetradeca-2,7-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 14:2
|
C21H37NO4
|
367.272259
|
|
LMFA07070124
|
2E,5Z-dodecadienoylcarnitine
|
3-[(2E,5Z)-dodeca-2,5-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 12:2
|
C19H33NO4
|
339.240959
|
|
LMFA07070124
|
2E,5Z-dodecadienoylcarnitine
|
3-[(2E,5Z)-dodeca-2,5-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 12:2
|
C19H33NO4
|
339.240959
|
|
LMFA07070125
|
2E,9Z-Octadecadienoylcarnitine
|
3-[(2E,9Z)-octadeca-2,9-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 18:2
|
C25H45NO4
|
423.334859
|
|
LMFA07070125
|
2E,9Z-Octadecadienoylcarnitine
|
3-[(2E,9Z)-octadeca-2,9-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 18:2
|
C25H45NO4
|
423.334859
|
|
LMFA07070126
|
7Z-Hexadecenoylcarnitine
|
3-[(7Z)-hexadeca-7-enoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:1
|
C23H43NO4
|
397.319209
|
|
LMFA07070126
|
7Z-Hexadecenoylcarnitine
|
3-[(7Z)-hexadeca-7-enoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:1
|
C23H43NO4
|
397.319209
|
|
LMFA07070127
|
2E,7Z-Hexadecadienoylcarnitine
|
3-[(2E,7Z)-hexadeca-2,7-dienoyloxy]-4-(trimethylazaniumyl)butanoate
|
CAR 16:2
|
C23H41NO4
|
395.303559
|